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Fas Modulation of Apoptosis
during Negative Selection of Thymocytes
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quist et al., 1994; Jameson et al., 1994). However, cellBruce A. Jacobson,5 Yunsheng Wang,2, 4
surface receptors in addition to the TCR are likely toPeter A. Lopez,7 Sherte Ju,6 Patricia W. Finn,1, 4
have important roles in determining the fate of thymo-and David L. Perkins2, 4
cytes (Page et al., 1993). For example, the CD4 and CD81Pulmonary Divisions
coreceptors have been shown to effect thymic develop-Brigham and Women’s and Beth Israel Hospitals
ment owing to both signal transduction and changes in2Laboratory of Immunogenetics and Transplantation
cell–cell avidity (Killeen and Littman, 1996). AdhesionRenal Division
due to LFA-1–ICAM-1 interactions has been shown toBrigham and Women’s Hospitals
be necessary for the generation of double positive (DP)3Renal Division
thymocytes (Fine and Kruisbeek, 1991). Apoptosis in-Children’s Hospital
duced by TCR signals has been reported to require a4Department of Medicine
costimulatory signal provided by CD28 (Punt et al.,Harvard Medical School
1994). Two receptor–ligand pairs of the tumor necrosisBoston, Massachusetts 02115
factor receptor (TNFR)/TNF families, CD30–CD30 ligand5Department of Microbiology
and CD40–gp39, have been shown tomodulate negative6Arthritis Center
selection of thymocytes (Amakawa et al., 1996; Foy etDepartment of Medicine
al., 1995).Boston University Medical Center
Fas (CD95), another member of the TNFR family, isBoston, Massachusetts 02118
expressed on most thymocytes. Previous reports have7Dana Farber Cancer Institute
shown that apoptosis of peripheral T cells by activation-Core Flow Cytometry Facility
induced cell death requires Fas signals in addition toBoston, Massachusetts 02115
TCR triggering (Brunner et al., 1995; Dhein et al., 1995;
Ju et al., 1995); however, the role of Fas during thymic
selection has not been established. In addition, the ex-
Summary pression of Fas ligand (FasL) in the thymus is controver-
sial (Nagata and Suda, 1995; Suda and Nagata, 1994;
A major mechanism maintaining immune tolerance is Suda et al., 1993). It has been demonstrated that anti-
the deletion of potentially autoreactive thymocytes by Fas monoclonal antibody (MAb) induces apoptosis of
apoptosis during development in the thymus. Previous thymocytes in vitro (Ogasawara et al., 1995); however,
it has been proposed by several groups that Fas is notreports suggest thatapoptosis is induced by highavid-
actually functional during thymic selection (Adachi etity signals transduced via the T cell receptor; however,
al., 1996; Giese and Davidson, 1992; Herron et al., 1993;the role of signals transduced by other cell surface
Kotzin et al., 1988; Mountz et al., 1990; Musette et al.,receptors during thymic selection remains poorly un-
1994; Sidman et al., 1992; Singer and Abbas, 1994;derstood. Fas, a member of the TNF receptor family,
Singer et al., 1994; Singer et al., 1989; Sytwu et al., 1996).has been shown to induce apoptosis in mature periph-
This interpretation is based upon analyses of the TCReral T cells; however, the effects of Fas on negative
repertoire of lpr mice, a mutant strain lacking detectableselection of thymocytes have not been previously de-
expression of Fas protein. In these reports, lpr micetected. Using a sensitive terminal deoxynucleotidyl
undergo the predicted deletion of TCR Vb chains intransferasemethod to detect apoptotic cells, we found
response to endogenous superantigens. In contrast, ourthat mutant Fas molecules in lpr mice decrease the
current results indicate that interactions between Fassensitivity of thymocytes to T cell receptor–mediated
and FasL can modulate the induction of apoptosis ofapoptosis and that blockade of Fas–Fas ligand interac-
thymocytes during negative selection. Specifically, wetions in vivo can inhibit antigen-induced apoptosis of
show that thymocytes from lpr mice have a decreasedthymocytes in non-lpr mice. Thus, we have shown that
susceptibility to TCR-induced apoptosis and that anti-Fas, in conjunction with antigen-specific signals, can
gen-specific deletion of thymocytes in normal mice canmodulate apoptosis during negative selection of thy-
be inhibited invivo by blocking the Fas–FasL interaction.mocytes.
Our results show that Fas–FasL interactions can also
modulate apoptosis of thymocytes.
Introduction
Results
Current models of thymic selection propose that the
fate of thymocytes (positive or negative selection or A hallmark of apoptosis of many cell types, including
neglect) is primarily determined by the avidity of the T thymocytes, is the activation of endogenous endonucle-
cell receptor (TCR) interaction with major histocompati- ases that cleave the genomic DNA into oligonucleoso-
bility complex (MHC) plus peptide antigen (Jameson et mal-sized fragments (Wyllie, 1980). To detect apoptotic
al., 1995). This is supported by observations that altered cells, we have adapted methods that use the enzyme
peptide ligands, or differing concentrations of a single terminal deoxynucleotidyl transferase (TdT) to incorpo-
rate fluorescent nucleotides onto the DNA fragmentspeptide, can switch the fateof thymocytes from negative
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Figure 1. Detection of Apoptotic Thymo-
cytes within a Normal Lymphocyte Scatter
Profile
BALB/c thymocytes were incubated in media
at 48C (a–c) or 1026 M dexamethasone (d–f)
for 1.5 hr, and cells were then stained with
TdT plus dCTP–Cy5 and analyzed by flow cy-
tometry. Results show dCTP–Cy5 (X axis) and
908 scatter (Y axis) of viable (gate R1) and
apoptotic (gate R2) cells (a and d), forward
scatter (X axis) and 908 scatter (Y axis) of
viable (gate R1; b and e) and apoptotic (gate
R2; c and f) cells. We collected 2 3 104 events
with a Becton Dickinson Vantage using Lysis
software. List-mode data were analyzed with
Winmidi software. Data are representative of
three independent experiments.
in apoptotic cells, rendering them detectable by flow using the sensitive TdT labeling method to detect apop-
totic cells. After incubation in media at 378C, the levelcytometry (Gavrieli et al., 1992; Gorczyca et al., 1992).
of spontaneous apoptosis was 13.5% in MRL-1 (FiguredCTP incorporation in freshly isolated control BALB/c
2b) versus only 4.3% in MRL-lpr thymocytes (Figure 2i),thymocytes or thymocytes cultured in media at 48C for
whereas at 48C, a temperature that inhibits the apoptotic1.5 hr was <1% (Figure 1a). However, after incubation
process, we detected <1.5% apoptotic cells in bothof BALB/c thymocytes for 1.5 hr in dexamethasone,34%
strains, which is similar to freshly isolated thymocytesof the cells are apoptotic based on increased incorpora-
(Figures 2a and 2h). The level of spontaneous apoptosistion of dCTP (Figure 1d). During apoptosis, phenotypic
was not affected in either the MRL-lpr or MRL-1 strainschanges include decreases in cell size (detected by de-
by the addition of the control human immunoglobulincreased forward scatter) and increases in membrane
G1 (IgG1) L6 MAb (Figures 2c and 2j) or Fas–Fc, a fusionblebbing (detected by increased 908 scatter). Analysis
protein composed of the extracellular domain of Fasof the forward and 908 scatter profiles of the viable (gate
linked to the Fc region of human IgG1 (Figures 2d andR1) and apoptotic (gate R2) thymocytes from the control
2k). The fact that Fas–Fc did not inhibit spontaneousgroup showed a normal scatter profile of the viable cells
apoptosis in either strain suggests that spontaneous(Figure 1b) and an insufficient number of apoptotic cells
apoptosis in vitro was due, at least in part, to Fas-inde-to analyze (Figure 1c), whereas the dexamethasone-
pendent signals. In addition, the increase in spontane-treated group showed that the apoptotic cells (Figure
ous apoptosis by the MRL-1 compared with the MRL-1f) had a decreased size (mean forward scatter 5 459)
lpr thymocytes may be partially due to apoptotic signalscompared with the viable population (Figure 1e) (mean
received in vivo prior to harvesting, and thus resistantforward scatter 5 483). Importantly, the size and 908
to in vitro inhibition by Fas–Fc. After incubation withscatter of both the normal and apoptotic populations
immobilized anti-CD3e MAb 2C11, the level of apoptosiswere within the normal scatter profiles of unmanipulated
increased to 24.6% in the MRL-1 (Figure 2e) comparedthymocytes, indicating that DNA strand breaks can be
with only 12.2% in the MRL-lpr thymocytes (Figure 2l).detected by TdT labeling before cells undergoing
Importantly, blocking Fas–FasL interaction with the
apoptosis become smaller than viable cells. At later
Fas–Fc fusion protein inhibited the 2C11-induced
timepoints, for example 4–8 hr, a population of small
apoptosis in the MRL-1 thymocytes (Figure 2g), whereas
apoptotic cells with forward scatter values less than the control L6 MAb had no effect (Figure 2f). Neither Fas–Fc
viable population was detected (data not shown). Thus, or L6 had inhibitory effects on the smaller increase in
these results indicate that TdT labeling is a sensitive 2C11-induced apoptosis in MRL-lpr thymocytes (Fig-
method capable of detecting cells while they are still ures 2n and 2m). In contrast, dexamethasone produced
within the normal thymocyte scatter profile. comparable increases above spontaneous levels of
apoptosis of 18.8% in MRL-1 and 22.1% in MRL-lpr
Thymocytes from Fas-Defective lpr Mice thymocytes, and, consistent with previous reports,
Have Decreased Sensitivity to Apoptosis Fas–Fc did not inhibit dexamethasone-induced apop-
The role of Fas in regulating apoptosis of thymocytes tosis in either strain (data not shown). These results
was analyzed by comparing the induction of apoptosis suggest that Fas–FasL interactions modulate apoptosis
in MRL-1/1 (MRL-1) and MRL-lpr/lpr (MRL-lpr) thymo- after TCR cross-linking.
cytes (Figure 2). MRL-lprmice do not express detectable MRL-1 thymocytes shown in Figures 2a–2g were ex-
levels of Fas owing to a retrotransposon insertion that amined for the expression of Fas (Figures 2o–2u). Previ-
disrupts correct splicing of Fas mRNA (Adachi et al., ous results have shown that Fas is expressed at high
1993). Our results indicate significant differences be- levels on late DP, at lower levels on more mature single
positive (SP), and at undetectable levels on most doubletween the induction of apoptosis in lpr and normal mice
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Figure 2. Decreased Susceptibility of MRL-lpr Thymocytes to Apoptosis In Vitro
Duplicate samples from two to four mice of MRL-1 (a–g) and MRL-lpr (h–n) thymocytes were incubated in RPMI media plus 10% fetal calf
serum at 48C (a and h) or at 378C (b and i) plus L6, a control human IgG1 MAb (Hellstrom et al., 1986) (c and j); Fas–Fc, a fusion protein
composed of the extracellular domain of Fas linked to the Fc region of human IgG1 (Ju et al., 1995) (d and k); anti–TCR CD3e MAb 145-2C11
(2C11) (Leo et al., 1987) (e and l); 2C11 plus L6 (f and m); or 2C11 plus Fas–Fc (g and n) and analyzed for apoptosis by TdT labeling. MRL-1
(o–u) and MRL-lpr (data not shown) thymocytes shown in (a)–(g) were also analyzed for cell surface expression of Fas by flow cytometry.
Data are representative of three independent experiments.
negative (DN) thymocytes (Andjelic et al., 1994; Drappa results showing that anti-Fas MAb can induce apoptosis
of thymocytes in vitro (Nishimura et al.,1995; Ogasawaraet al., 1993; Nishimura et al., 1995; Ogasawara et al.,
1993). Our results show that thymocytes undergoing et al., 1995). As expected, the MRL-lpr thymocytes did
not express detectable levels of Fas (data not shown).apoptosis from the MRL-1 strain express high levels of
cell surface Fas, whereas few cells lacking Fas expres- These results show that susceptibility to Fas-induced
apoptosis correlates with expression of high levels ofsion become apoptotic. This is consistent with previous
Immunity
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Figure 3. Both Mutant Fas Receptor and Fas–FasL Blockade Inhibit TCR-Induced Apoptosis
(a) We intraperitoneally injected 4- to 6-week-old MRL-1 (open bars) and MRL-lpr mice (hatched bars) with 100 mg of 2C11 MAb (2C11) or
PBS plus 100 mg of L6 (control). After 10 hr, thymocytes were harvested, labeled with dCTP–Cy5 with TdT, and analyzed by flow cytometry
as previously described. The percentage of apoptotic cells was determined in duplicate samples. The percentage of apoptotic cells in PBS
control groups (MRL-1, 1.9%; MRL-lpr, 2.9%) was subtracted from the 2C11 groups. Data are representative of three independent experiments.
(b) We intraperitoneally injected 4- to 6-week-old BALB/c mice with 100 mg of 2C11 MAb (open bars), 100 mg of 2C11 MAb plus 150 mg of
Fas–Fc (hatched bars), or PBS plus 150 mg of L6. After 10 hr, thymocytes were harvested and labeled with dCTP–Cy5 with TdT and analyzed
by flow cytometry. The percentage of apoptotic cells in PBScontrol groups (2.3%) was subtracted from the2C11 groups. Data are representative
of three independent experiments.
(c) We intraperitoneally injected 4- to 6-week-old TCR transgenic DO mice with 1000 mg of OVA324-39 peptide (open bars), 1000 mg of
OVA324-39 peptide plus 150 mg of Fas–Fc (hatched bars), or PBS plus 150 mg of L6. After 10 hr, thymocytes were harvested and labeled
with dCTP–Cy5 with TdT and analyzed by flow cytometry. The percentage of apoptotic cells in PBS control groups (0.7%) was subtracted
from the OVA324-39 peptide groups. Data are representative of two independent experiments.
Fas. However, a subset of the MRL-lpr thymocytes did effect of blocking Fas–FasL interactions with the Fas–Fc
fusion protein in vivo in BALB/c mice (Figure 3b). Theseundergo spontaneous apoptosis, and the percentage of
cells in this subset was increased after TCR cross-link- results show that MAb 2C11 induced apoptosis in 31.7%
of thymocytes. In contrast, mice receiving Fas–Fc plusing, although at consistently lower levels compared with
the MRL-1 mice. The simplest interpretation of these 2C11 had apoptosis inhibited to 8.7%. Apoptosis in con-
trol mice receiving saline was consistently less thanresults is that both Fas-dependent and Fas-independent
mechanisms can regulate apoptosis of thymocytes. 2.3%. Thus, blockade of the Fas–FasL interaction in
vivo can inhibit TCR-induced apoptosis of thymocytesHowever, because low level expression of Fas mRNA
has been detected in lpr mice (Adachi et al., 1993; Ma- in normal mice.
nani et al., 1994), we cannot rigorously exclude the pos-
sibility that apoptosis of the MRL-lpr thymocytes is due Fas–Fc Inhibits Antigen-Specific Negative
Selection In Vivoto the expression of functional but undetectable levels
of Fas protein. To determine the physiological role of Fas-dependent
apoptosis of thymocytes, we investigated the effect of
blocking Fas–FasL interactions with the Fas–Fc fusionThymocytes from lpr Mice Have Decreased
Sensitivity to TCR-Induced Apoptosis In Vivo protein in vivoduring antigen-specific negative selection
using non-lpr DO-11.10 (DO) TCR transgenic mice, sinceTo confirm that the decreased sensitivity of lpr thymo-
cytes to TCR-induced apoptosis also occurred in vivo previous reports had shown that injection of the OVA
protein induces apoptosis of thymocytes in these micein a normal thymic milieu, we injected MRL-1 and MRL-
lpr mice with the anti-TCR CD3e MAb 2C11 (Figure 3a), (Murphy et al., 1990). Consistent with the previous re-
ports, the peptide OVA324-39 induced apoptosis of thy-which has previously been shown to induce apoptosis
of thymocytes in vivo (Shi et al., 1991). Consistent with mocytes from DO mice; importantly, Fas–Fc reduced
the percentage of apoptotic thymocytes by >90% (Fig-our in vitro results, these data show that the induction of
apoptosis of MRL-1 thymocytes (24.2%) was increased ure 3c). Thus, blockade of the Fas–FasL interaction can
inhibit antigen-specific negative selection in DO TCRcompared with MRL-lpr thymocytes (9.61%) (Figure 3a).
Control mice of both strains injected with phosphate- transgenic mice.
buffered saline (PBS) had a low incidence of apoptosis
that was not significantly different (1.9% and 2.9%, re- Fas–Fc Blocks Apoptosis of FashiTCRint
DP Thymocytesspectively). Thus, thymocytes from lpr mice have a de-
creased sensitivity to TCR-induced apoptosis both in The deletion of thymocytes during negative selection
has been shown by multiple laboratories to occur at thevitro and in vivo.
late DP stage in cells expressing intermediate levels of
TCR (Swat et al., 1991a). Therefore, we examined theBlockade of Fas–FasL Interactions Inhibits
TCR-Induced Apoptosis in Non-lpr Mice phenotype of the viable and apoptotic thymocytes
shown in Figure 3c by four-color flow cytometry forTo analyze the role of Fas–FasL interactions in wild-type
mice with normal Fas expression, we investigated the TdT labeling (Figures 4a–4d), expression of TCR (Figures
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Figure 4. Inhibition of Apoptosis by Fas–Fc during Antigen-Induced Negative Selection In Vivo
Thymocytes from mice given PBS (a), OVA324-39 (b), OVA324-39 plus L6 (c), and OVA324-39 plus Fas–Fc (d) were analyzed for incorporation
of fluoresceinated dCTP by TdT labeling (X axis) and cell number (Y axis); gate M1 delineates viable cells, and gate M2 dCTP1 apoptotic
cells. Cells from gates M1 and M2 were analyzed for forward scatter (X axis) and TCR expression (Y axis) ([e]–[h] and [i]–[j], respectively).
Data are representative of two independent experiments.
4e–4j), and expression of CD4 and CD8 (Figures 5a–5j). range of 75%–77%) thymocytes was not significantly
different among the four groups (Figures 5a–5d). Analy-Apoptosis detected by TdT labeling of freshly isolated
thymocytes from DO mice is consistently <1% (data not sis of CD4 and CD8 expression showed that the mice
treated with OVA324-39 and OVA324-39 plus L6 (Figuresshown), a level comparable with thymocytes from mice
receiving PBS (Figure 4a). At 12 hr after injection of 5b and 5c), but not with PBS or OVA324-39 plus Fas–Fc
(Figures 5a and 5d), accumulated a population ofOVA324-39, 41% of the thymocytes were apoptotic (Fig-
ure 4b). In contrast, blockade of Fas–FasL interactions CD4loCD8lo cells (gate R2). To confirm that DP thymo-
cytes progress to a CD4loCD8lo phenotype duringwith Fas–Fc resulted in apoptosis of only 3% of the
thymocytes following injection of OVA324-39 (Figure apoptosis, we determined the frequency of apoptotic
cells within gates R1 and R2. In the mice given PBS or4d). As expected, control L6 did not inhibit apoptosis
in OVA324-39-treated mice (Figure 4c). OVA324-39 plus Fas–Fc only 0.4% and 5%, respectively,
of the cells within gate R1 were apoptotic (Figures 5eNext, we analyzed the level of TCR expression of the
viable (gate M1) and apoptotic (gate M2) cells shown in and 5h), whereas 38%–45% were apoptotic in the mice
treated with OVA324-39 or OVA324-39 plus L6 (FiguresFigures 4a–4d. Only 4% and 5% of the apoptotic cells
expressed high levels of TCR in mice receiving OVA324- 5f and 5g). Strikingly, 91% and 93% of the thymocytes
expressing decreased levels of CD4 and CD8 (gate R2)39 or OVA324-39 plus L6, respectively, whereas most of
the apoptotic cells (93%–95%) expressed intermediate from mice receiving OVA324-39 (Figure 5i) or OVA324-39
plus L6 (Figure 5j), respectively, were apoptotic. Again,levels of TCR (Figures 4i and 4j). There were insufficient
apoptotic events to analyze in the mice treated with there were insufficient apoptotic events in the Fas–Fc-
treated group to analyze CD4 and CD8 expression (dataPBS or Fas–Fc (data not shown). In contrast with the
apoptotic cells, 11%–14% of the viable cells (gate M1) not shown). Analysisof the forward scatter of cells within
gate R2 shows that the CD4loCD8lo cells are smallerexpressed high levels of TCR (Figures 4e–4h). Together,
these results suggest that the thymocytes undergoing than the population within gate R1 (Figures 5i and 5j).
Together, these results suggest that the apoptotic cellsapoptosis predominantly express intermediate levels of
TCR, which is consistent with previous studies of nega- progress from larger cells within gate R1 to smaller cells
within gate R2. Previous reports showed that thymo-tive selection.
After 18–24 hr, the percentage of DP thymocytes was cytes undergoing apoptosis express lower levels of CD4
and CD8 (Kishimoto et al., 1995; Swat et al., 1991b). Ourmarkedly decreased (data not shown); however, 12 hr
after administration of peptide the percentage of DP (a analysis confirms reduced levels of CD4 and CD8, but
Immunity
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Figure 5. Fas–Fc Inhibits Apoptosis of the TCRintCD4loCD8lo DP Thymocytes In Vivo during Antigen-Induced Negative Selection
Using list-mode data, the same cells shown in Figure 4 were also analyzed for expression of CD4 (X axis) and CD8 (Y axis) (a–d). CD4hiCD8hi
(gate R1) and CD4loCD8lo (gate R2) thymocytes were analyzed by forward scatter (X axis) and dCTP incorporation (Y axis) ([e]–[h] and [i]–[j],
respectively); gate R3 includes cells labeled with dCTP–Cy5 (percentage of apoptotic cells is shown). Dataare representative of two independent
experiments. Four DO TCR transgenic mice were injected intraperitoneally with PBS (a and e), 1 mg of OVA324-39 (b, f, and i), 1 mg of
OVA324-39 plus 150 mg of L6 (e, g, and j), or 1 mg of OVA324-39 plus 150 mg of Fas–Fc (d and h). After 12 hr, thymocytes were harvested
and processed as previously described, except that the cells were stained with anti-TCRab–phycoerythrin, anti-CD4–FITC, and anti-CD8–biotin
plus red 613 in addition to TdT labeling with dCTP–Cy5.
indicates that the decreased fluorescence correlates apoptotic cells correspond to the small thymocytes ob-
served with the Nomarski optics. As expected, dualwith decreased size. In conjunction with the analysis of
TCR expression, these results indicate that apoptotic color immunofluorescence to detect TCR expression in
addition to dCTP incorporation showed that viable cellsthymocytes are predominantly CD4loCD8lo cells that ex-
press intermediate levels of TCR. Previous observations with and without detectable TCR expression were pres-
ent (Figures 6e and 6f). Importantly, all of the observedhad shown that DP thymocytesare particularly suscepti-
ble to induction of apoptosis by anti-Fas MAb or FasL- apoptotic cells expressed detectable levels of TCR (Fig-
ure 6f). The expression of TCR on the apoptotic cells isexpressing cells (Arase et al., 1994; Nishimura et al.,
1995). Our results show that Fas–Fc inhibits apoptosis consistent with our previous results (Figures 2–4) show-
ing that TCR signals promote Fas-dependent apoptosis.and the appearance of the CD4loCD8lo DP thymocytes
in vivo during antigen-induced negative selection. In addition, these data are consistent with previous re-
sults showing that during apoptosis cells decrease in
size owing to condensation and blebbing.Morphology of Apoptotic Thymocytes
To analyze the morphology of the apoptotic thymocytes
in conjunction with cell surface expression of TCR, cy-
tospin preparations were made from thymocytes from Fas–Fc Inhibits Apoptosis of Predominantly
Cortical ThymocytesDO mice given OVA324-39 plus L6 or OVA324-39 plus
Fas–Fc (Figure 6). Examination with Nomarski optics Localization of apoptosis within the thymus was deter-
mined by immunohistochemistry with TdT-mediatedshowed an increased proportion of small thymocytes
from mice administered OVA324-39 (Figure 6b) com- dUTP-digoxigenin nick-end labeling (TUNEL) (Figure 7).
Thymus sections from DO mice that received PBSpared with OVA324-39 plus Fas–Fc (Figure 6a). Analysis
of the same slides by immunofluorescence to detect showed low levels of basal apoptosis (Figure 7c),
whereas mice that received OVA324-39 plus L6 hadapoptotic cells by dCTP incorporated with TdT labeling
showed increased apoptotic cells in the mice receiving increased apoptosis (Figure 7b). In contrast, the mice
that received OVA324-39 plus Fas–Fc had levels ofpeptide alone (Figure 6d) compared with the mice re-
ceiving Fas–Fc plus peptide (Figure 6c). Most of the apoptosis that were similar to the PBS control (Figure
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Figure 6. Differential Interference Contrast and Immunofluoresence Microscopy of Apoptotic Cells
Thymocytes from DO mice treated with OVA324-39 plus Fas–Fc (a, c, and e) or OVA324-39 plus L6 (b, d, and f) were stained with phycoerythrin-
labeled anti-TCRab MAb H57-59 (Pharmingen) and then labeled with dCTP–biotin plus streptavidin–FITC by TdT as described in Figure 1.
Arrowheads indicate small cells (b) that incorporated dCTP (d) and labeled with anti-TCR MAb (f). Slides were prepared with a Cytospin
centrifuge. The samples were then visualized with a differential interference contrast microscope (Nikon Diaphot 300) using the Nomarski-
DCI (a and b) and Diaphot EPI-fluorescence attachments for fluorescein (green) (c and d) and phycoerythrin (red) and fluorescein (green)
fluorescence (e and f). The images were processed and analyzed using the Oncor Image System. Data are representative of two independent
experiments.
7a). This effect was evident as early as 4 hr and at least often appeared in clusters, and the size of the clusters
increased with OVA324-39 treatment, probably owingup to 12 hr after treatment (data not shown).
Consistent with previous reports, the apoptotic cells to engulfment by phagocytic macrophages (Kishimoto
Figure 7. Fas–Fc Inhibits Apoptosis of Predominantly Cortical Thymocytes
Thymi were harvested from DO mice 4 hr after receiving PBS (c), OVA324-39 plus L6 (b), or OVA324-39 plus Fas–Fc (a). Duplicate 6 mm
cryosections of mouse thymus were stained by the TUNEL method according to the Apotag in situ apoptosis detection protocol or without
TdT enzyme to control for endogenous peroxidase activity (Oncor) (Gavrieli et al., 1992). Slides were developed with diamino-benzidine as
the substrate. Sections were counterstained with methyl green. Apoptotic cells are stained brown. Images were analyzed at 43 magnification.
Septae are apparent in the sections. Arrows indicate medullary regions.
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et al., 1995; Liblau et al., 1996). Apoptosis in all three our results in both the MRL-1 and BALB/c strains using
the anti–TCR CD3e MAb (2C11) that recognizes all TCRsgroups was localized predominantly in the cortex, with
infrequent apoptotic cells visualized in the medullary expressing the CD3 complex strongly support our argu-
ment that modulation of thymocyte apoptosis by Fas–regions. These results show that Fas–Fc inhibits anti-
gen-induced apoptosis of thymocytes that are predomi- FasL interactions is not limited to a small subset of TCRs
or to a narrow range of TCR/peptide–MHC avidities.nantly localized to the cortical regions.
Another explanation for our detection of apoptotic cells
may be the increased sensitivity of detecting TdT-
Discussion labeled apoptoticcells by flow cytometry compared with
other methods including ladder gels and fluorescent
Our results show that thymocytes from lpr mice have staining of subdiploid DNA content. Our results show
decreased susceptibility to TCR-induced apoptosis. To that TdT labeling can detect apoptotic cells with normal
confirm the physiological significance of this observa- size parameters before they become smaller than viable
tion, we also demonstrated that blocking Fas–FasL sig- cells. Thus, our use of the TdT method combined with
nals inhibits antigen-induced apoptosis of thymocytes flow cytometry may partially account for our detection
during negative selection in vivo. Differential interfer- of Fas modulation of thymocyte apoptosis; however, it
ence contrast and immunofluorescence microscopy is unlikely this is sufficient to account completely for the
showed that Fas–FasL blockade inhibited progression difference between our results and previous studies.
of thymocytes to small TCR1 apoptotic cells. Using four- A major difference between our experiments and pre-
color flow cytometry, we showed that Fas–FasL block- vious studies is the kinetics of the analyses. Our experi-
ade inhibited apoptosis of FashiTCRintCD41CD81 DP thy- ments focused on early timepoints, including 1.5–2 hr
mocytes. In addition, based on immunohistochemistry in in vitro assays and 4–12 hr in in vivo experiments,
with the TUNEL assay, Fas–FasL blockade inhibited whereas none of the prior studies reporting that Fas had
apoptosis of thymocytes that were predominantly lo- no effect on thymocyte deletion examined timepoints
cated in the cortical regions. Negative selection com- earlier than 24 hr. For example, some studies showed
monly occurs at the FashiTCRintCD41CD81 DP stage of the predicted deletion of specific TCR Vb chains by
thymocyte development in the cortex or at the cortical- endogenous superantigens in adult lpr mice (Adachi et
medullary junction. Thus, all of our results are in al., 1996; Giese and Davidson, 1992; Herron et al., 1993;
agreement with a model in which Fas–FasL interactions Kotzin et al., 1988; Mountz et al., 1990; Musette et al.,
can modulate apoptosis of thymocytes during negative 1994; Singer et al., 1989) or mice made deficient in Fas
selection. by homologous recombination (Adachi et al.,1996). Pep-
Consistent with our results, several studies have tide antigens have also been shown to delete thymo-
shown decreased deletion of thymocytes in lpr mice. cytes in TCR transgenic lpr mice. For example, Singer
For example, Mountz and coworkers (1994) noted de- and Abbas (1994) analyzed thymocyte deletion in 2B4
creased deletion of CD8 SP thymocytes in male C57Bl/ TCR transgenic lpr mice at day 7 after three injections
6-lpr compared with C57Bl/61 H-Y TCR transgenic mice of peptide antigen. Their results showed comparable
(44% and 10%, respectively). Also, decreased deletion deletion in lpr and normal strains analyzed at day 7. Also,
of lpr-derived thymocytes was observed in chimeric Sytwu et al. (1996) analyzed the HNT TCR transgenic
mice (Matsumoto et al., 1991), and increased emigration lpr strain and found comparable deletion by peptide
of thymocytes was detected in lpr mice following toler- antigen in lpr and normal strains between 1 and 7 days
ance induction (Zhou et al., 1993). Additionally, in in after peptide injection. However, none of these experi-
vitro studies Fas signals have been shown to induce ments analyzed timepoints earlier than 24 hr. At the
apoptosis of thymocytes (Ogasawara et al., 1995; Yo- earlier timepoints analyzed in our studies, we detected
nehara et al., 1994; Fisher et al., 1996). However, a num- quantitative differences between MRL-lpr and MRL-1
ber of previous studies did not detect Fas-dependent strains. Also, in experiments investigating lpr mice, Fas-
deletion of thymocytes (Adachi et al., 1996; Giese and independent mechanisms could at least partially com-
Davidson, 1992; Herron et al., 1993; Kotzin et al., 1988; pensate for the deficiency of Fas and promote thymo-
Mountz et al., 1990; Musette et al., 1994; Sidman et al., cyte deletion. Together, these observations support a
1992; Singer and Abbas, 1994; Singer et al., 1994; Singer model in which Fas signals modulate TCR-induced
et al., 1989; Sytwu et al., 1996). The prior studies analyz- apoptosis at early timepoints. It is possible that Fas-
ing TCR Vb deletion in lpr mice investigated thymocyte independent signals modulate apoptosis at later time-
deletion by endogenous superantigens, suggesting the points.
possibility that Fas modulates apoptosis induced by In addition to our results demonstrating that Fas can
peptide antigens, but not superantigens. However, this modulate negative selection of thymocytes, two other
is unlikely based on results showing that the cytochrome members of the TNFR family, CD40 and CD30, have
and hemagglutinin peptides induce thymocyte deletion recently been shown to modulate apoptosis of thymo-
in TCR transgenic lpr models (Singer and Abbas, 1994; cytes. In models of negative selection, deletion was
Sytwu et al., 1996). Another possibility is that Fas modu- blocked by the loss of gp39 function when the antigen
lates apoptosis of thymocytes only in specific mouse or superantigen was endogenously expressed, but not
strains. We analyzed two different genetic backgrounds when the antigen was exogenously administered (Foy
and obtained similar results. Therefore, it is unlikely that et al., 1995). Interestingly, our results are reciprocal.
our results differ with those of others because of the Blockade of Fas–FasL inhibits deletion in response to
exogenous antigens, whereas several groups haveunique characteristics of a specific strain. In addition,
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the guidelines of the Committee on Animals of Harvard Medicalshown normal deletion to endogenous superantigens in
School, and those prepared by the Committee on Care and Use oflpr mice (Adachi et al., 1996; Giese and Davidson, 1992;
Laboratory Animals of the Institute of Laboratory Animal Resources,Herron et al., 1993; Kotzin et al., 1988; Mountz et al.,
National Research Council. BALB/c, MRL-1/1 (MRL-1), and MRL-
1990; Musette et al., 1994; Sidman et al., 1992; Singer lpr/lpr (MRL-lpr) mice were purchased from Jackson Laboratories
and Abbas, 1994; Singer et al., 1989). In CD30-deficient (Bar Harbor, ME). DO-11.10 (DO) TCR transgenic mice, specific for
mice, negative selection was shown to be impaired to the OVA324-39 peptide in association with I-Ad, were originally pro-
vided by Dr. D. Loh (Washington University, St. Louis, MO) and bredendogenous antigens; however, the effect of exogenous
in our animal facility.antigens was not evaluated (Amakawa et al., 1996). To-
gether, these observations suggest the hypothesis that
different members of the TNFR family may modulate Peptides
apoptosis of thymocytes in different contexts, such as The peptide OVA324-39 (SQAVHAAHAEINEAGR) was synthesized
by standard Fmoc chemistry using an Applied Biosystems biopoly-different stages of development or in response to differ-
mer synthesizer at the Brigham and Women’s Hospital Biopolymerent signals. As indicated by our results, only Fas has
Laboratory. All peptides were purified by high pressure liquid chro-been shown to block apoptosis of thymocytes in vivo
matography. Composition was confirmed by amino acid analysisin response to exogenous antigens.
using a 6300 Amino Acid Analyzer (Beckman) and plasma-desorp-
A recent report showing that Fas and the p55 TNFR tion time-of-flight mass spectroscopy.
may cross-talk by cytoplasmic protein–protein interac-
tions involving MORT1 (FADD) and TRADD (Varfolomeev
Activation of Thymocytes In Vitroet al., 1996) suggests a model in which multiple signals
Thymocytes were prepared as previously described. In brief, dupli-
transduced by members of the TNFR/TNF families (in- cate samples of MRL-1 and MRL-lpr thymocytes from two to four
cluding Fas/FasL, CD30/CD30L, CD40/gp39, and TNFR) mice were incubated at 2 3 105 cells per well in media plus 10%
could be integrated by cross-talk into one signal that fetal calf serum at 48C (negative control) or 378C plus 20 mg/ml L6,
an isotype-matched control human IgG1 MAb (Hellstrom et al.,modulates apoptosis. In this model, signals by members
1986), 20 mg/ml Fas–Fc, a fusion protein composed of the extracellu-of the TNFR family could have redundant, or at least
lar domain of Fas linked to the Fc region of human IgG1 (Ju et al.,partially overlapping, functions. Relevant to this notion,
1995), 20 mg/ml immobilized anti-TCR CD3e MAb 145-2C11 (2C11)lpr mice that have a congenital Fas deficiency may de-
(Leo et al., 1987), 20 mg/ml 2C11 plus 20 mg/ml L6, or 20 mg/ml
velop compensatory mechanismsto regulate thymocyte 2C11 plus 20 mg/ml Fas–Fc for 1.5 hr.
deletion that are not functional in our experiments ana-
lyzing non-lpr mice (for example, the CD30–CD30L,
Antigen-Specific Deletion of Thymocytes In VivoCD40–gp39, or TNFR–TNF receptor–ligand pairs could
BALB/c, MRL-lpr, or DO TCRtransgenic mice were injected intraper-be overexpressed in lpr mice). Consistent with this hy-
itoneally with 100 mg of 2C11 MAb or 1 mg of OVA324-39 peptide
pothesis, splenic and thymic cells from lpr mice express in PBS alone or with 150 mg of Fas–Fc or 150 mg of L6, and thymi
increased quantities of TNFa compared with non-lpr were harvested at the indicated times.
controls (Tsai et al., 1995). Alternatively, the signals by
members of the TNFR family could function indepen-
Flow Cytometry
dently. It will be important to determine whether the Fas- Freshly isolated thymocytes were stained with fluorescent labeled
dependent and Fas-independent signals are integrated MAb and analyzed by flow cytometry as previously described (Per-
into a single response and coordinately regulate apop- kins et al., 1996). In brief, 1 3 106 cells were incubated with saturating
tosis or whether they mediate apoptosis in different sub- concentrations of fluorescent antibodies in 50 ml for 30 min at 48C
in PBS, 1% mouse serum, 5% bovine calf serum, and 0.1% NaN3.sets of thymocytes during different stages of maturation
The cells were then fixed in 1% paraformaldehyde in PBS (pH 7.4)and selection.
for 15 min and treated with 100% ethanol for 3 hr at 2208C. CellsPrevious reports showed that Fas was important in
were washed twice and then incubated at 378C for 15 min with 5 Uthe regulation of TCR-induced apoptosis of mature pe-
of TdT (Promega, Madison, WI), and 6.25 pmol per well dCTP–Cy5
ripheral T cells (Brunner et al., 1995; Dhein et al., 1995; (Amersham, Arlington Heights, IL) in 13 TdT buffer (Promega). Cells
Ju et al., 1995; Singer and Abbas, 1994; Sytwu et al., were washed and 1 3 104 to 5 3 104 events were analyzed with
1996). More recently, TNF has also been shown to in- Lysis software on a Becton Dickinson FACS Vantage using 488
(fluorescein isothiocyanate [FITC], phycoerythrin [PE], and red 613)duce apoptosis of both CD8 and CD4 T cells (Sytwu et
and 633 (Cy5) nm excitation wavelengths. Fluorescence was de-al., 1996; Zheng et al., 1995). Thus, at least two members
tected at 525 (FITC), 590 (PE), 613 (red 613), and 670 (Cy5) nm.of the TNFR family can regulate apoptosis of mature T
Graphics were prepared using the WinMDI software (Joseph Trotter,cells. Previous reports have also implicated members
Scripps Institute, La Jolla, CA).
of the TNFR/TNF families, including CD30/CD30L and
possibly CD40/gp39, in the regulation of apoptosis of
MAbsthymocytes. In this report our results demonstrate that
The MAbs specific for CD4 (GK1.5; Dialynas et al., 1983) and CD8Fas-dependent signals can modulate apoptosis of thy-
(53.6; Ledbetter and Herzenberg, 1979) were purified from hybrid-mocytes during early phases of negative selection.
oma supernatant by passing over a protein A column and eluted with
Thus, it is likely that multiple receptors can regulate 125 mM sodium acetate. Fractions were immediately neutralized to
apoptosis of thymocytes. In future studies, it will be pH 8 by titrating 1 M Na2CO3. Purified MAb was conjugated to FITC
important to understand the roles of Fas-dependent and and long-arm biotin, respectively (Sigma, St. Louis, MO). In brief, 1
Fas-independent apoptosis of thymocytes. mg of purified MAb was alkalinized by the addition of 1 M Na2CO3
(pH 9.4; 1:10 [v/v]) to make a 100 mM Na2CO3 buffered solution.
We added 100 mg of conjugate dissolved in anhydrous DMSO perExperimental Procedures
milligram of MAb for 30 min at room temperature. Free dye was
separated from labeled MAb by elution through a gel filtration col-Mice
umn (G50 Sephadex) using PBS plus0.02% NaN3. Anti-Fas and anti-All mice used were 4–6 weeks old and were housed in virus anti-
body–free facilities. Animals were maintained in accordance with TCRb were obtained from Pharmingen (San Diego, CA).
Immunity
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Differential Interference Contrast and Dialynas, D., Quan, Z., Wall, K., Pierres, A., Quintans, J., Loken, M.,
Pierres, M., and Fitch, F. (1983). Characterization of the murine TImmunofluorescence Microscopy
Freshly isolated thymocytes were stained with fluorescent MAb and cell surface molecule designated L3T4, identified by monoclonal
antibody GK-1.5: similarity of L3T4 to the human Leu3/T4 moleculethen labeled with dCTP–biotin plus streptavidin–FITC by TdT as
described. Slidespreviously coated with Biobond (Goldmark Biolog- and thepossible involvement of L3T4 in class II MHC antigen reactiv-
ity. J. Immunol. 133, 2445–2452.icals, Phillipsburg, NJ) were prepared by spinning 5 3 105 cells at
500 rpm for 5 min using a Cytospin centrifuge. Coverslips were Drappa, J., Brot, N., and Elkon, K.B. (1993). The fas protein is ex-
mounted on air-dried slides with Vectashield (Vector Laboratories pressed at high levels on CD41CD81 thymocytes and activated
Inc., Burlingame, CA). The samples were then visualized with a mature lymphocytes in normalmice but not in the lupus-prone strain,
differential interference contrast microscope (Nikon Diaphot 300) MRL lpr/lpr. Immunology 90, 10340–10344.
using the Nomarski-DCI and Diaphot EPI-fluorescence attachments
Fine, J.S., and Kruisbeek, A.M. (1991). The role of LFA-1/ICAM-1for fluorescein (green) and PE (red) fluorescence. The images were
interactions during murine T lymphocyte development. J. Immunol.processed and analyzed using the Oncor Image System (Gaithers-
147, 2852–2859.
burg, MD).
Fisher, G.H., Lenardo, M.J., and Zuniga-Pflucker, J.C. (1996). Syn-
ergy between T cell receptor and Fas (CD95/APO-1) signaling inImmunohistochemistry
mouse thymocyte death. Cell. Immunol. 169, 99–106.Duplicate 6 mm cryosections of mouse thymus were stained by the
Foy, T.M., Page, S.M., Waldschmidt, T.J., Schoneveld, A., Laman,TUNEL method according to the Apotag in situ apoptosis detection
J.D., Masters, S.R., Tygrett, L., Ledbetter, J.A., Aruffo, A., Classen,protocol (Oncor). Control sections were stained without the TdT
E., Xu, J.C., Flavell, R.A., Oehen, S., Hedrick, S.M., and Noelle, R.J.enzyme to control for endogenous peroxidase activity. Slides
(1995). An essential role for gp39, the ligand for CD40, in thymicwere developed with diamino-benzidine as the substrate. Sec-
selection. J. Exp. Med. 182, 1377–1388.tions were counterstained with methyl green. The microscopy im-
ages were processed and analyzed using the Oncor Image System. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identification
of programmed cell death in situ via specific labeling of nucleic DNA
fragmentation. J. Cell Biol. 119, 493–501.Acknowledgments
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